Book Chapters/Editorials/Reviews



Roubille, C., Pelletier, J.P., Martel-Pelletier, J.: Drug/Agent Treatments for Osteoarthritis   Present and Future. In: Osteoarthritis: Pathogenesis, diagnosis, available treatments, drug safety, regenerative and personalized medicine. Kapoor, M. and Mahomed, N.N., eds. Publisher: Sringer. New York, NY, U.S.A.  Chapter 10, pp 191-210, 2015.

Roubille, C., Martel-Pelletier, J., Sellam, J., Pelletier, J.P., Raynauld, J.P., Roubille, F.: Osteoarthritis and cardiovascular diseases: is meta-inflammation the missing link? J. Cardiol. Ther. 2(3):315-320, 2015. 

Martel-Pelletier, J., Farran, A., Montell, E., Verges, J., Pelletier, J.P.: Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules 20(3):4277-4289, 2015.




Articles
(For prior publications please search online on PubMed Pelletier, Jean-Pierre and/or Martel-Pelletier, Johanne )



Li, Y-H., Tardif, G., Hum, D., Kapoor, M., Fahmi, H., Pelletier, J.P., Martel-Pelletier, J.: The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target. Arthritis Res. Ther. 18:172, 2016.

Valverde-Franco, G., Lussier, B., Hum, D., Wu, J., Hamadjida, A., Dancause, N., Fahmi, H., Kapoor, M., Pelletier, J.P., Martel-Pelletier, J.: Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo. Arthritis Care Res.18(1):65, 2016.

Pelletier, J.P., Martel-Pelletier, J., Rannou, F., Cooper, C.: Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Sem. Arthritis Rheum. 45:(4):S22-27, 2016.

Hochberg, M.C., Martel-Pelletier, J., Monfort, J., Möller, I., Castillo, J.R., Arden, N., Berenbaum, F., Blanco, F.J., Conaghan, P.G., Doménech, G., Henrotin, Y., Pap, T., Richette, P., Sawitzke, A., du Souich, P., Pelletier, J.P., on behalf of the MOVES Investigation Group: Combined chondrotin sulphate and glucosamine for painful knee osteoarthritis: a multicenter, randomized, double-blind, non-inferiority trial versus celecoxib. Ann. Rheum. Dis. 75(1):37-44, 2016.





Abstracts/Presentations



Pelletier, J.P., Raynauld, J.P., Beaulieu, A., Bessette, L., Morin, F., de Brum-Fernandes, A.J., Abram, F., Dorais, M., Martel-Pelletier, J.: In a two-year double-blind randomized controlled multicenter study, chondroitin sulfate was significantly superior to celecoxib at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients. Ann. Rheum. Dis. 75(Suppl 2):836, 2016; Arthritis Rheum. 67 (Suppl 10):1243, 2015. (highlighted in Medscape. Nov. 10, 2015 news@medscape.net).

Pelletier, J.P.: Efficacy and safety of oral and topical NSAIDs plus analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Osteoporos Int. 27(Suppl 1):S65-66, 2016.

Pelletier, J.P.: Safety and risk/benefit ratio of diacerein in the management of osteoarthritis. Osteoporos Int. 27(Suppl 1):S68, 2016.

Otis, C., Gervais, J., Guillot, M., Gervais, J.A., Gauvin, D., Péthel, C., Authier, S., Dansereau, M.A., Sarret, P., Martel-Pelletier, J., Pelletier, J.P., Troncy, E.: Concurrent validity of different pain assessment methods in the rat osteoarthritis MIA model. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Abstract P21, pp 65-66. Montreal, Canada. (April 2015).

Monteiro, B.P., Klinck, M., Moreau, M., Guillot, M., Steagall, P., Pelletier, J.P., Martel-Pelletier, J., Gauvin, D., del Castillo, J., Troncy, E.: Analgesic efficacy of tramadol administered orally for two weeks in cats with naturally occurring osteoarthritis. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Abstract P17, pp 64. Montreal, Canada. (April 2015).

Valverde-Franco, G., Lussier, B., Fahmi, H., Hum, D., Wu, J., Dancause, N., Hamadjida, A., Pelletier, J.P., Kapoor, M., Martel-Pelletier, J.: In vivo cartilage-specific deletion of ephrin-B2 in mice results in bone development leading to osteoarthritis features. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Abstract P29, pp 69. Montreal, Canada. (April 2015).

Guillot, M., Rialland, P., Taylor, Polly, M., Rousseau, J.A., Beaudoin, J.F., Chartrand, G., Pelletier, J.P., Martel-Pelletier, J., de Guise, J.A., Lecomte, R., Troncy, E.: Osteoarthritis-associated pain in cats: proofs of central sensitization development. 3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Abstract P09, pp 60. Montreal, Canada. (April 2015).

Martel-Pelletier, J., Raynauld, J.P., Roubille, C., Pelletier, J.P.: Are muscle area, muscle fat and adipokines risk factors for osteoarthritis?  3rd World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Abstract S14, pp 33. Montreal, Canada. (April 2015).






All rights reserved ArthroLab Inc.